Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria

被引:252
作者
Lim, K-C [2 ]
Chow, P. K-H [1 ,2 ,3 ]
Allen, J. C. [2 ]
Siddiqui, F. J. [2 ,4 ]
Chan, E. S-Y [2 ,4 ]
Tan, S-B [2 ,4 ]
机构
[1] Singapore Gen Hosp, Dept Gen Surg, Singapore 169608, Singapore
[2] Duke NUS Grad Med Sch, Ctr Quantitat Med, Singapore, Singapore
[3] Natl Canc Ctr, Dept Surg Oncol, Singapore, Singapore
[4] Singapore Clin Res Inst, Singapore, Singapore
关键词
TO-TREAT ANALYSIS; HEPATIC RESECTION; RADIOFREQUENCY ABLATION; PARTIAL-HEPATECTOMY; CIRRHOTIC-PATIENTS; SURGICAL-TREATMENT; PROGNOSTIC-FACTORS; TRANSPLANTATION; STAGE; RECURRENCE;
D O I
10.1002/bjs.8915
中图分类号
R61 [外科手术学];
学科分类号
100210 [外科学];
摘要
Background: Long-term overall survival after liver resection in patients with hepatocellular carcinoma (HCC) within the Milan criteria has been reported to improve in recent years. This study systematically reviewed the outcomes of surgical resection for HCC in patients with good liver function and meeting the Milan criteria for early HCC, published in the past 10 years. Methods: A literature search was conducted in PubMed for papers on outcomes of surgical resection for HCC published between January 2000 and December 2010. Cochrane systematic review methodology was used for this review. The primary outcome was overall survival. Secondary outcomes included operative mortality and disease-free survival. Studies that focused on geriatric populations, paediatric populations, a subset of the Milan criteria (such solitary tumours) or included patients with incidental tumours were excluded, as were case reports, conference abstracts, and studies with a large proportion of ChildPugh grade C liver cirrhosis or unknown ChildPugh status. Results: Of 152 studies reviewed, two randomized clinical trials and 27 retrospective case series were eligible for inclusion. The 5-year overall survival rate after resection of HCC ranged from 27 to 81 (median 67) per cent, and the median disease-free survival rate from 21 to 57 (median 37) per cent. There was a trend towards improved overall survival in recent years. The operative mortality rate ranged from 0 to 5 (median 0.7) per cent. Conclusion: Surgical resection offers good overall survival for patients with HCC within the Milan criteria and with good liver function, although recurrence rates remain high. Outcomes have tended to improve in more recent years. Copyright (c) 2012 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:1622 / 1629
页数:8
相关论文
共 58 条
[1]
Superiority of transplantation versus resection for the treatment of small hepatocellular carcinoma [J].
Baccarani, Umberto ;
Isola, Miriam ;
Adani, Gian L. ;
Benzoni, Enrico ;
Avellini, Claudio ;
Lorenzin, Dario ;
Bresadola, Fabrizio ;
Uzzau, Alessandro ;
Risaliti, Andrea ;
Beltrami, Antonio P. ;
Soldano, Franca ;
De Anna, Dino ;
Bresadola, Vittorio .
TRANSPLANT INTERNATIONAL, 2008, 21 (03) :247-254
[2]
Beighiti J, 2002, HEPATO-GASTROENTEROL, V49, P41
[3]
Surgical management of early-stage hepatocellular carcinoma: Resection or ransplantation? [J].
Bellavance, Emily C. ;
Lumpkins, Kimberly M. ;
Mentha, Gilles ;
Marques, Hugo P. ;
Capussotti, Lorenzo ;
Pulitano, Carlo ;
Majno, Pietro ;
Mira, Paulo ;
Rubbia-Brandt, Laura ;
Ferrero, Alessandro ;
Aldrighetti, Luca ;
Cunningham, Steven ;
Russolillo, Nadia ;
Philosophe, Benjamin ;
Barroso, Eduardo ;
Pawlik, Timothy M. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2008, 12 (10) :1699-1708
[4]
Small hepatocellular carcinoma in child a cirrhotic patients:: Hepatic resection versus transplantation [J].
Bigourdan, JM ;
Jaeck, D ;
Meyer, N ;
Meyer, C ;
Oussoultzoglou, E ;
Bachellier, P ;
Weber, JC ;
Audet, M ;
Doffoël, M ;
Wolf, P .
LIVER TRANSPLANTATION, 2003, 9 (05) :513-520
[5]
Multimodal approaches to the treatment of hepatocellular carcinoma [J].
Cabibbo, Giuseppe ;
Latteri, Federica ;
Antonucci, Michela ;
Craxi, Antonio .
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2009, 6 (03) :159-169
[6]
Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation [J].
Cha, CH ;
Ruo, L ;
Fong, Y ;
Jarnagin, WR ;
Shia, J ;
Blumgart, LH ;
DeMatteo, RP .
ANNALS OF SURGERY, 2003, 238 (03) :315-321
[7]
A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma [J].
Chen, MS ;
Li, JQ ;
Zheng, Y ;
Guo, RP ;
Liang, HH ;
Zhang, YQ ;
Lin, XJ ;
Lau, WY .
ANNALS OF SURGERY, 2006, 243 (03) :321-328
[8]
Partial hepatectomy as first-line treatment for patients with hepatocellular carcinoma [J].
Cillo, Umberto ;
Vitale, Alessandro ;
Brolese, Alberto ;
Zanus, Giacomo ;
Neri, Daniele ;
Valmasoni, Michele ;
Bonsignore, Pasquale ;
Grigoletto, Francesco ;
Burra, Patrizia ;
Farinati, Fabio ;
D'Amico, Davide Francesco .
JOURNAL OF SURGICAL ONCOLOGY, 2007, 95 (03) :213-220
[9]
Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: A population-based study [J].
Davila, JA ;
Morgan, RO ;
Shaib, Y ;
McGlynn, KA ;
El-Serag, HB .
GASTROENTEROLOGY, 2004, 127 (05) :1372-1380
[10]
Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of bologna experience [J].
Del Gaudio, M. ;
Ercolani, G. ;
Ravaioli, M. ;
Cescon, M. ;
Lauro, A. ;
Vivarelli, M. ;
Zanello, M. ;
Cucchetti, A. ;
Vetrone, G. ;
Tuci, F. ;
Ramacciato, G. ;
Grazi, G. L. ;
Pinna, A. D. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (06) :1177-1185